Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis (Q39780220)

14 September 2017

Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis (English)

1 reference

14 September 2017

0 references

Kurtz MB

1

1 reference

14 September 2017

Bernard EM

2

1 reference

14 September 2017

Edwards FF

3

1 reference

14 September 2017

Marrinan JA

4

1 reference

14 September 2017

Dropinski J

5

1 reference

14 September 2017

Douglas CM

6

1 reference

14 September 2017

Armstrong D

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

39

1 reference

14 September 2017

8

1 reference

14 September 2017

1784-1789

1 reference

Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthase

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Synergy between cilofungin and amphotericin B in a murine model of candidiasis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Papulacandin B: an Inhibitor of Glucan Synthesis in Yeast Spheroplasts

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

LY121019 inhibits Neurospora crassa growth and (1-3)-beta-D-glucan synthase

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Effect of aculeacin A, a wall-active antibiotic, on synthesis of the yeast cell wall

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Effects of cilofungin (LY121019) on carbohydrate and sterol composition of Candida albicans

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Comparison of Azoles against Aspergilli in vitro and in an Experimental Model of Pulmonary Aspergillosis

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162826

Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study

15 June 2018

1 reference

12 December 2020

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species

1 reference

12 December 2020

In vitro and in vivo anti-Candida activity and toxicology of LY121019

1 reference

12 December 2020

L-687,781, a new member of the papulacandin family of beta-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity

1 reference

12 December 2020

Activity of cilofungin (LY 121019), a new lipopeptide antibiotic, on the cell wall and cytoplasmic membrane of Candida albicans. Structural modifications in scanning and transmission electron microscopy

1 reference

12 December 2020

Pneumocandins from Zalerion arboricola. I. Discovery and isolation

1 reference

12 December 2020

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

12 December 2020

Effect of papulacandin B on glucan synthesis in Paracoccidioides brasiliensis

1 reference

12 December 2020

Anti-Candida activity and toxicology of LY121019, a novel semisynthetic polypeptide antifungal antibiotic

1 reference

12 December 2020

The effect of aculeacin A and papulacandin B on morphology and cell wall ultrastructure in Candida albicans

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.39.8.1784

1 reference

14 September 2017

1 reference

14 September 2017

1 reference